Spots Global Cancer Trial Database for ovarian epithelial carcinoma
Every month we try and update this database with for ovarian epithelial carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Ovarian Epithelial Carcinoma | NCT05856643 | Ovarian Epithel... | SZ011 CAR-NK | 18 Years - 80 Years | Shantou University Medical College | |
| Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Ovarian Epithelial Carcinoma | NCT05856643 | Ovarian Epithel... | SZ011 CAR-NK | 18 Years - 80 Years | Shantou University Medical College | |
| Developing a Test for the Detection of Ovarian Cancer | NCT04794322 | Ovarian Neoplas... Ovarian Epithel... Fallopian Tube ... High Grade Ovar... Stage I Ovarian... Stage II Ovaria... Stage III Ovari... Stage IIIA Ovar... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Ovar... Stage IIIC Ovar... Stage IV Ovaria... Stage IVA Ovari... Stage IVB Ovari... | Uterine lavage,... Blood sample Pap smear | 30 Years - | Massachusetts General Hospital | |
| Developing a Test for the Detection of Ovarian Cancer | NCT04794322 | Ovarian Neoplas... Ovarian Epithel... Fallopian Tube ... High Grade Ovar... Stage I Ovarian... Stage II Ovaria... Stage III Ovari... Stage IIIA Ovar... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Ovar... Stage IIIC Ovar... Stage IV Ovaria... Stage IVA Ovari... Stage IVB Ovari... | Uterine lavage,... Blood sample Pap smear | 30 Years - | Massachusetts General Hospital | |
| Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy | NCT00377429 | Ovarian Cancer | catumaxomab | 18 Years - | Neovii Biotech | |
| Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy | NCT05763199 | Ovarian Epithel... Fallopian Tube ... Peritoneal Carc... | AHCC Chemotherapy Placebo | 18 Years - | University of California, Davis | |
| A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression | NCT01536743 | Ovarian Epithel... | PD0332991 | 18 Years - | Jonsson Comprehensive Cancer Center | |
| A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression | NCT05325866 | Solid Tumors | Bemarituzumab | 18 Years - 99 Years | Amgen | |
| Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites | NCT00326885 | Malignant Ascit... | catumaxomab | 18 Years - | Neovii Biotech | |
| Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy | NCT00377429 | Ovarian Cancer | catumaxomab | 18 Years - | Neovii Biotech |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
